Molecular defects in the ABCA1 pathway affect platelet function

Pathophysiology of Haemostasis and Thrombosis

Volumn 35, Issue 1-2, 2006, Pages

  Schmitz, Gerd ^a   Schambeck, Christian M ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

ABCA1; AP 3; HDL; Membrane raft; Platelet

Indexed keywords

2 AMINO 3 PHOSPHONOPROPIONIC ACID; ABC TRANSPORTER A1; CHOLESTEROL; COLLAGEN; GLYCOPROTEIN VI; GUANINE NUCLEOTIDE BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; PHOSPHOLIPID; POTASSIUM CHANNEL; PROTEIN TYROSINE KINASE; PURINE P2Y12 RECEPTOR; SERINE; SNARE PROTEIN; SPHINGOSINE 1 PHOSPHATE; SYNTAXIN;

ATHEROGENESIS; CELL DAMAGE; CELL MEMBRANE; CHEDIAK HIGASHI SYNDROME; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; GENE CONTROL; GENE MUTATION; GOLGI COMPLEX; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; LIPOFUSCINOSIS; LYSOSOME; NONHUMAN; OCULAR ALBINISM; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN INTERACTION; PROTEIN TARGETING; SCOTT SYNDROME; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 33748460535     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093563     Document Type: Conference Paper

References (75)

1. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost. 2003;1:1897-1905.
2. Rosenson RS, Lowe GD. Effects of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis. 1998;140:271-280.
3. Osamah H, Mira R, Sorina S, Shlomo K, Michael A. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets. Br J Clin Pharmacol. 1997;44:77-83.
4. Schick BP, Schick PK. Cholesterol exchange in platelets, erythrocytes and megakaryocytes. Biochim Biophys Acta. 1985;833:281-290.
5. Relou IAM, Gorter G, von Rijn HJ, Akkerman JW. Platelet activation by the apoB/E receptor-binding domain of LDL. Thromb Haemost 2002; 87: 880-7.
6. Knorr M, Locher R, Vogt E, Vetter W, Block LH, Ferracin F. Rapid activation of human platelets by low concentrations of low-density lipoproteins via phosphatidylinositol cycle. Eur J Biochem 1988; 172:753-9.
7. Andrews HE, Aitken JW, Hassall DG, Skinner VO, Bruckdorfer KR. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. Biochem J 1987;242:559-64.
8. Nofer J-R, Tepel M, Kehrel B, Wierwille S, Walter M, Seedorf U, Assmann G. Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia. Circulation 1997;95:1370-7.
9. Hackeng C, Relou IA, Pladet MW, Gorter G, van Rijn HJ, Akkerman JW. Early platelet activation by low density lipoprotein via p38MAP kinase. Thromb Haemost 1999;82:1749-56.
10. Quinton TM, Kim S, Jin J, Kunapuli SP. Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation. J Thromb Haemost 205;3:1036-41.
11. Zhang X, Chattopadhyay A, Ji QS, Owen JD, Ruest PJ, Carpenter G. Focal adhesion kinase promotes phospholipase C-gamma I activity. Proc Natol Acad Sci USA 1999;96:9021-26.
12. Cheng HC, Guan JL. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Nat Acad Sci USA 1994;91:10148-52.
13. Siess W, Zangl KJ, Essler M, Bauer M, Brandi R, Corrinth C. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 1999; 96: 6931-6.
14. Mahfouz MM, Kummerow FA. Oxidized low-density lipoprotein (LDL) enhances thromboxane A(2) synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect. Prostaglandins Other Lipid Mediat 2000; 62:183-200.
15. Murphy CT, Elmore M, Kellie S, Westwick J. The relationship between cytosolic Ca2+, sn-1,2-diacylglycerol and inositol 1,4,5-triphosphate elevation in platelet-activating-factor-stimulated rabbit platelets. Influence of protein C kinase on production of signal molecules. Biochem J 1991; 287:255-61.
16. Motohashi K, Shibata S, Ozaki Y, Yatomi Y, Igarashi Y. Identification of lysophospholipid receptors in human platelets: the relaton of two agonists, lysophosphatidic acid and sphingosine 1-phosphate. FEBS Lett 2000; 468:189-93.
17. Siess W. Athero- and thrombogenic actioins of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta 2002; 1582:204-15.
18. Tokumura A, Sinomiya J, Kishimoto S, Tanaka T, Kogure K, Sugiura T, Satouchi K, Waku K, Fukuzawa K. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids. Biochem J 2002; 365:617-28.
19. Korporaal SJA, Gorter G, von Rijn HJM, Akkermari J-WN. Effect of oxidation on the platelet-activating properties of low-density lipoprotein. Arterioscler Thromb Vasc Biol 2005; 25:867-72.
20. Maschberger P, Bauer M, Baumann-Siemons J, Zangl KJ, Negrescu EV, Reininger AJ, Siess W. Mildly oxidized low density lipoprotein rapidly stimulates via activation of the lysophosphatidic acid receptor Src family and Syk tyrosine kinases and Ca2+ influx in human platelets. J Biol Chem 2000;275:19159-66.
21. Cho MJ, Pestina TI, Steward SA, Lowell CA, Jackson CW, Gartner TK. Role of Src family kinase Lyn in TxA2 production, adenosine diphosphate secretion, Akt phosphorylation, and irreversible aggregation in platelets stimulated with γ-thrombin. Blood 2002;99:2442-7.
22. Stenberg PE, Pestina TI, Barrie RJ, Jackson CW. The Src family kinases, Fgr, Gyn, Lck, and Lyn, colocalize with coated membranes in platelets. Blood 1997;898:2384-93.
23. Chen LY, Mehta P, Mehta JL. Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidized LDL on platelet function. Circulation 1996; 93: 1740-6.
24. Chen M, Kakutani M, Naruko T, Ueda M, Narumiya S, Masaki T. Activation-dependent surface expressionof LOX-1 in human platelets. Biochem Biophys Res Commun 2001;282:153-8.
25. O'Connell DJ, Rozenvayn N, Flaumenhaft R. Phosphatidylinositol 4,5-bisphosphate regulates activation-induced platelet microparticle formation. Biochemistry 2005; 44: 6361-70.
26. Nofer J-R, Walter M, Kehrel B, Wiewille S, Tepel M, Seedorf U, Assmann G. HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositides-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate. Arterioscler Thromb Vasc Biol 1998;18:861-9.
27. 3 (GPIIb-IIIa). Atherosclerosis 2001; 154:23-9.
28. Nofer J-R, Tepel M, Kehrel B, Walter M, Seedorf U, Assmann G, Zidek W. High density lipoproteins enhance the Na+/H+ antiport in human platelets. Thromb Haemost 1996;75:635-41.
29. Makela JH, Isomaa B. Perturbation of the platelet plasma membrane is not sufficient for inhibition of thrombin-induces PKC-activity. Chem Biol Interact 1993;86:187-98.
30. Zhang B, Tomura H, Kuwabara A, Kimura T, Miura S, Noda K, Okajima F, Saku K. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL cholesterol and apolipoproteins. Atherosclerosis 2005; 178:199-205.
31. Meyer zu Heringdorf D. Lysophospholipid receptor-dependent and -independent calcium signalling. J Cell Biochem 2004; 92: 937-48.
32. Ohmori T, Yatomi Y, Osada M, Ozaki Y. The intracellular action of sphingosine 1-phosphate in GPVI-mediated Ca2+ mobilization in platelets. Thromb Res 2005; 115:409-15.
33. Watanabe N, Nakajima H, Suzuki H, Oda A, Matsubara Y, Moroi M, Terauchi Y, Kadowaki T, Suzuki H, Koyasu S, Ikeda Y, Handa M. Functional phenotype of phosphoinositide 3-kinase p85alpha-null platelets characterized by an impaired response to GP VI stimulation. Blood 2003; 102:541-8.
34. Chen J, De S, Damron DS, Chen WS, Hay N, Byzova TV. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 2004;104:1703-10.
35. Woulfe D, Jiang H, Morgans A, Monks R, Birnbaum M, Brass LF. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 2004; 113:441-50.
36. Barlage S, Boettcher D, Boettcher A, Dada A, Schmitz G. High density lipoprotein modulates platelet function. Cytometry A 2006; 69: 196-9.
37. Drobnik W, Borsukova H, Bottcher A Pfeiffer A, Liebisch G, Schutz GJ, Schindler H, Schmitz G. Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic. 2002;3:268-278.
38. Shrimpton CN, Borthakur G, Larrucea S, Cruz MA, Dong JF, Lopez JA. Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation. J Exp Med. 2002;196:1057-1066.
39. Diederich W, Orsó E, Drobnik W, Schmitz G. Apolipoprotein AI and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42. Atherosclerosis 2001; 159: 313-24.
40. Engel T, Lüken A, Bode G, Hobohm U, Lorkowski S, Schlüter B, Rust S, Cullen P, Pech M, Assmann G, Seedorf U. ADP-ribosylation (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol export. FEBS Lett 2004; 566:241-6.
41. Nofer JR, Remaley AT, Feuerbom R, Wolinnska I, Engel T, von Eckardstein A, Assmann G. Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter. J Lipid Res 2006;47:794-803.
42. Tsukamoto K, Hirano K, Tsuji K, Ikegami C, Zhongyan Z, Nishida Y, Ohama T, Matsuura F, Yamashita S, Matsuzawa Y. ATP-binding cassette transporter-1 induces rearrangement of actin cytoskeletons possibly through CdC42/N-WASP. Biochem Biophys Res Comm 2001; 287:757-65.
43. Munehira Y, Ohnishi T, Kawamoto S, Furuya A, Shizara K, Imamura M, Yokota T, Takeda S, Amachi T, Matsuo M, Kioka N, Ueda K. Alpha1-syntrophin modulates turnover of ABCA1. J Biol Chem 2004;279:15091-5.
44. Büchler C, Böttcher A, Bared SM, Probst MC, Schmitz G. The carboxyterminus of the ATP-binding cassette transporter A1 interacts with a beta2-syntrophin/utrophin complex. Biochem Biophys Res Commun 2002; 293:759-65.
45. Bared SM, Buechler C, Boettcher A, Dayoub R, Sigruener A, Grandl M, Rudolph C, Dada A, Schmitz G. Association of ABCA1 with syntaxin 13 and flotillin-1 and enhanced phagocytosis in Tangier cells. Mol Biol Cell 2004;15: 5399-5407.
46. Huang L, Kuo YM, Gitschier J. The pallid gene encodes a novel, syntaxin 13-interacting protein involved in platelet storage pool deficiency. Nat Genet 1999;23:329-32.
47. Falcon-Perez JM, Starcevic M, Gautam R, Dell'Angelica EC. BLOC-1, a novel complex containing the pallidin and muted proteins involved in the biogenesis of melanosomes and platelet-dense granules. J Biol Chem 2002; 277: 28191-9.
48. Li W, Rusiniak ME, Chintala S, Gautam R, Novak EK, Swank RT. Murine Hermansky-Pudlak syndrome genes: regulators of lysosome-related organelles. Bioessays 2004; 26: 616-28.
49. Jedlitzschky G, Tirschmann K, Lubenow LE, Nieuwenhuis HK, Akkerman JWN, Greinacher A, Kroemer HK. The nucleotide transporter MRP (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood 2004; 104:3603-10.
50. Klucken J, Büchler C, Orso E, Kaminski WE, Porsch-Ozcurumez M, Liebisch G, Kapinsky M, Diederich W, Drobnik W, Dean M, Allikmets R, Schmitz G. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci USA 2000; 97:817-22.
51. Lloyd VK, Sinclair DA, Alperyn M, Grigliatti TA. Enhancer of garnet/deltaAP-3 is a cryptic allele of the white gene and identifies the intracellular transport system for the white protein. Genome 2002; 45:296-312.
52. Mackenzie SM, Howells AJ, Cox GB, Ewart GD. Sub-cellular localization of the White/Scarlet ABC transporter to pigment granule membranes within the compound eye of Drosophila melanogaster. Genetica 2000; 108:239-52.
53. Kyttala A, Yliannala K, Schu P, Jalanko A, Luzio JP. AP-1 and AP-3 facilitate lysosomal targeting of Batten disease protein CLN3 via its dileucine motif. J Biol Chem 2005;280:10277-83.
54. Bodzioch M, Orso E, Klucken J Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999;22:347-351.
55. Orso E, Broccardo C, Kaminski WE, Bottcher A, Liebisch G, Drobnik W, Gotz A, Chambenoit O, Diederich W, Langmann T, Spruss T, Luciani MF, Rothe G, Lackner KJ, Chimini G, Schmitz G. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice, Nat. Genet 2000; 24: 192-196.
56. Nofer JR, Herminghaus G, Brodde M, Morgenstern E, Rust S, Engel T, Seedorf U, Assmann G, Bluethmann H, Kehrel BE. Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease). J Biol Chem 2004; 279: 34032-7.
57. Combes V, Coltel N, Alibert M, van Eck M, Raymond C, Juhan-Vague I, Grau GE, Chimini G. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am J Pathol 2005; 166:295-302.
58. Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta 2004;1636:119-28.
59. Albrecht C, McVey JH, Elliott JI, Sardini A, Kasza I, Mumford AD, Naoumova RP, Tuddenham EG, Szabo K, Higgins CF. A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome. Blood 2005; 106: 542-9.
60. Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999; 274:29019-29024.
61. Gibbins JM, Okuma M, Farndale R, Barnes M, Watson SP. Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain. FEBS Lett 1997;413:255-9.
62. Ezumi Y, Kodama K, Uchiyama T, Takayama H. Constitutive and functional association of the platelet collagen receptor glycoprotein VI-Fc receptor gamma-chain complex with membrane rafts. Blood 2002; 99:3250-5.
63. Nieswandt B, Bergmeier W, Eckly A, Schulte V, Ohlmann P, Cazenave JP, Zirngibl H, Offermanns S, Gachet C. Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation. Blood 2001; 97:3829-.
64. Jung SM, Ohnuma M, Watanabe N, Sonoda M, Handa M, Moroi M. Analyzing the mechanism of Rapl activation in platelets: Rap1 activation is related to the release reaction mediated through the collagen receptor GPVI. Thromb Res 2005, Dec 24, Epub.
65. Larson MK, Chan H, Kahn ML, Taylor AM, Fahre JE, Mortenson RM, Conley PB, Parise LV. Identification of P2Y12-dependent and - independent mechanisms of glycoprotein VI-mediated Rap1 activation of platelets. Blood 2003;101:1409-15.
66. Shankar H, Murugappan S, Kim S, Jin J, Ding Z, Wickman K, Kunapuli SP. Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses. Blood 2004; 104: 1335-1343.
67. Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004; 113: 340-345.
68. Dangelmaier C, Jin J, Smith JB, Kunapuli SP. Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositides-3 kinase pathway. Thromb Haemost 2001; 85: 341-8.
69. Huang CL, Feng S, Hilgemann DW. Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature 1998; 391: 803-806.
70. Sui JL, Petit-Jacques J, Logothetis DE. Activation of the atrial KACh channel by the betagamma subunits of G proteins or intracellular Na+ ions depends on the presence of phosphatidylinositol phosphates. Proc Natl Acad Sci U S A 1998; 95: 1307-1312.
71. Kobayashi T, Washiyama K, Ikeda K. Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs. Neuropsychopharmacology 2004; 29: 1841-1851.
72. Lei Q, Talley EM, Bayliss DA. Receptor-mediated inhibition of G protein-coupled inwardly rectifying potassium channels involves G(alpha)q family subunits, phospholipase C, and a readily diffusible messenger. J Biol Chem 2001; 276: 16720-16730.
73. Kobrinsky E, Mirshahi T, Zhang H, Jin T, Logothetis DE. Receptor-mediated hydrolysis of plasma membrane messenger PIP2 leads to K+-current desensitization. Nat Cell Biol 2000; 2: 507-514.
74. Mao J, Wang X, Chen F, Wang R, Rojas A, Shi Y, Piao H, Jiang C. Molecular basis for the inhibition of G protein-coupled inward rectifier K(+) channels by protein kinase C. Proc Natl Acad Sci U S A 2004; 101: 1087-1092.
75. Ma D, Zerangue N, Raab-Graham K, Fried SR, Jan YN, Jan LY. Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart. Neuron 2002; 33:715-29.